Monopoly Rights for High-Demand Repaglinide Therapy

High Profit Margins from Stable Chronic Diabetes Segment

Repohike Edge: Trusted Mealtime Glucose Control

Repohike Edge: Trusted Mealtime Glucose Control

Low Investment, Full Technical Marketing Support
Start Your High-Value Diabetes Business Today

Home/Products /repaglinide-0-5mg-tablet

Repohike 0.5 tablet

Composition : Repaglinide (0.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹1/-

Repohike Tablet (Repaglinide 0.5mg) is a high-profit, essential chronic care product built for our PCD Pharma Franchise partners.

This tablet contains Repaglinide, an effective oral anti-diabetic agent used to help Type 2 Diabetes patients manage their post-meal blood sugar levels. Given the lifelong nature of diabetes management, this product guarantees stable, consistent monthly refills and provides exceptional financial stability.

Why Repohike is Your Key to Profit:

  1. Guaranteed Recurring Revenue: Diabetes management requires daily, long-term medication. Repaglinide ensures consistent, predictable monthly refills and superior financial stability from the massive chronic care patient base.

  2. Excellent Chronic Care Margin: Positioned as an essential drug in the high-volume metabolic segment, this product commands competitive pricing while securing superior profit margins due to guaranteed patient loyalty and stable demand.

  3. Physician Loyalty: The proven efficacy and specific role of Repaglinide in managing mealtime glucose spikes build strong, reliable prescription loyalty from endocrinologists and general practitioners.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this essential chronic care formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.

Contact us today to capture this max-margin chronic care segment!

Read More

About the Product

Repohike Tablet (Repaglinide 0.5mg) is a high-profit, essential chronic care product built for our PCD Pharma Franchise partners.

This tablet contains Repaglinide, an effective oral anti-diabetic agent used to help Type 2 Diabetes patients manage their post-meal blood sugar levels. Given the lifelong nature of diabetes management, this product guarantees stable, consistent monthly refills and provides exceptional financial stability.

Why Repohike is Your Key to Profit:

  1. Guaranteed Recurring Revenue: Diabetes management requires daily, long-term medication. Repaglinide ensures consistent, predictable monthly refills and superior financial stability from the massive chronic care patient base.

  2. Excellent Chronic Care Margin: Positioned as an essential drug in the high-volume metabolic segment, this product commands competitive pricing while securing superior profit margins due to guaranteed patient loyalty and stable demand.

  3. Physician Loyalty: The proven efficacy and specific role of Repaglinide in managing mealtime glucose spikes build strong, reliable prescription loyalty from endocrinologists and general practitioners.

  4. Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this essential chronic care formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.

Contact us today to capture this max-margin chronic care segment!

Some patients may experience hypoglycemia, mild gastrointestinal discomfort, nausea, or headache. Rarely, allergic reactions or significant drops in blood sugar levels may occur and require immediate medical attention.

Repohike 0.5 Tablet is indicated for the management of type 2 diabetes mellitus in adults, especially for controlling post-meal hyperglycemia. It helps maintain stable blood glucose levels, reduces the risk of diabetes-related complications, and can be used alone or in combination with other antidiabetic medications as part of a comprehensive diabetes management plan.

Sodium Hyaluronate is generally well-tolerated. Mild side effects may include temporary blurred vision, slight stinging, or a watery sensation after instillation. Allergic reactions are rare but may present as redness, itching, or swelling. If persistent discomfort occurs, consult an ophthalmologist.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation